Electrolyte / antiarrhythmic / anticonvulsant
Magnesium sulfate
Adult dose
Dose: Hypomagnesaemia: 5–10mmol IV. Severe asthma: 1.2–2g (5–8mmol) IV over 20 min. Eclampsia/severe pre-eclampsia: loading 4g IV over 5–15 min, then 1g/h infusion for 24h. Torsades: 2g IV over 1–2 min
Route: IV/IM
Frequency: per indication
Clinical pearls
- Eclampsia: continuous infusion + monitor reflexes/RR/UO; calcium gluconate 10% 10mL is the antidote
- Severe asthma 2nd-line; torsades in normo-/hyperkalaemia
Contraindications
- Heart block
- Severe renal impairment (caution)
- Myasthenia gravis
Side effects
- Hypotension
- Bradycardia
- Loss of patellar reflex
- Respiratory depression at high levels (>4 mmol/L)
- Hypermagnesaemia
Interactions
- Neuromuscular blockers (potentiation)
- Calcium-channel blockers
- Aminoglycosides
- Digoxin
Monitoring
- Reflexes
- RR
- Urine output
- Serum Mg in renal impairment
- ECG
Reference: BNF; NICE NG133; UK Resus Council; BTS/SIGN asthma; https://bnf.nice.org.uk/drugs/magnesium-sulfate/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines